doi: 10.1016/j.celrep.2021.109706 103 ZhangZHHuiYWanQHuXYWangHLiuCCet al
Orally delivered semaglutide resulted in considerable weight reduction over 26 weeks in the PIONEER clinical trials, surpassing other GLP-1-RA medications
Synergistic effect of -glucosidase inhibitors and dipeptidyl peptidase 4 inhibitor treatment
In SELECT, semaglutide showed a 20% reduction in major adverse cardiovascular events (MACE) including cardiovascular death, non-fatal heart attack, or non-fatal stroke with the benefits seen regardless of patients baseline age, sex, race, ethnicity, and body mass index (BMI)
Xenical works on an enzyme in your gut called pancreatic lipase, which reduces fat absorption in your gut by about 30%
Achieving these stringent endpoints, as outlined in the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE-II) consensus ( Research into mucosal healing has highlighted pathways involving interleukin-20 (IL-20), claudin-2 (CLDN2), and notoginsenoside R1 (NGR1) ( Figure 1 illustrates the differences in immune cell distribution within the intestinal crypts under homeostatic conditions compared with the inflammatory microenvironments of CD and UC
